SCHEMBL21075702

SCHEMBL21075702

Cc1cc(Cl)cc(C(c2ccccc2)N2CCC(N)CC2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 4/20 0.46
ADRA2A P08913 4/20 0.46
CHRM1 P11229 4/20 0.46
DRD1 P21728 4/20 0.46
DRD3 P35462 4/20 0.46
SLC6A3 Q01959 4/20 0.46
KCNH2 Q12809 4/20 0.46
SLC6A2 P23975 3/20 0.46
SLC6A4 P31645 3/20 0.46
ADRA1A P35348 3/20 0.46
HTR1A P08908 2/20 0.46
TBXA2R P21731 2/20 0.46
BCL2 P10415 1/20 0.46
HRH3 Q9Y5N1 1/20 0.46
CACNA2D1 P54289 1/20 0.45
CACNA1B Q00975 1/20 0.45
CACNB1 Q02641 1/20 0.45
CYP2D6 P10635 4/20 0.45
CYP2C19 P33261 2/20 0.45
TSHR P16473 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21075238 0.90 CACNA2D1 (0.53) CHRM2ADRA2ACHRM1DRD1DRD3
SCHEMBL11381417 0.83 OPRM1 (0.58) CHRM2ADRA2ACHRM1DRD1DRD3
SCHEMBL11384842 0.82 OPRM1 (0.59) CHRM2ADRA2ACHRM1DRD1DRD3
SCHEMBL2306320 0.81 L3MBTL3 (0.61) CHRM2ADRA2ACHRM1DRD1DRD3
Hydrochloric Acid SCHEMBL6984780 0.80 L3MBTL3 (0.59) CHRM2ADRA2ACHRM1DRD1DRD3
SCHEMBL19083885 0.79 CACNA2D1 (0.53) CHRM2ADRA2ACHRM1DRD1DRD3
SCHEMBL17428330 0.79 CACNA2D1 (0.53) CHRM2ADRA2ACHRM1DRD1DRD3
SCHEMBL19075516 0.77 CACNA2D1 (0.51) CHRM2ADRA2ACHRM1DRD1DRD3
SCHEMBL20697765 0.77 CACNA2D1 (0.51) CHRM2ADRA2ACHRM1DRD1DRD3
SCHEMBL21075626 0.77 NPSR1 (0.44) CHRM2ADRA2ACHRM1DRD1DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3166939-B1 THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF GENENTECH INC (US) 2019-06-05 EP disclosed